We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$120B
AUM Growth
+$2.68B
Cap. Flow
-$4.47B
Cap. Flow %
-3.72%
Top 10 Hldgs %
12.85%
Holding
2,691
New
107
Increased
717
Reduced
1,008
Closed
96

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$505M
2
VRSN icon
VeriSign
VRSN
+$382M
3
BAX icon
Baxter International
BAX
+$374M
4
ADI icon
Analog Devices
ADI
+$219M
5
CHWY icon
Chewy
CHWY
+$206M

Sector Composition

Rank Sector Weight
1 Technology 25.17%
2 Healthcare 14.7%
3 Financials 13.17%
4 Industrials 10.74%
5 Consumer Discretionary 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPTI icon
1276
Karyopharm Therapeutics
KPTI
$161M
$2.46M ﹤0.01%
25,469
OGS icon
1277
ONE Gas
OGS
$5.06B
$2.44M ﹤0.01%
31,421
+20,200
+180% +$1.41M
NVR icon
1278
NVR
NVR
$17.3B
$2.43M ﹤0.01%
411
-185
-31% -$976K
RBCP
1279
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
$2.41M ﹤0.01%
23,025
+17,025
+284% +$1.9M
STER
1280
DELISTED
Sterling Check Corp. Common Stock
STER
$2.41M ﹤0.01%
117,306
+2,842
+2% +$67.2K
SNCY
1281
DELISTED
Sun Country Airlines
SNCY
$2.38M ﹤0.01%
87,343
+14,084
+19% +$420K
FDS icon
1282
Factset
FDS
$10.1B
$2.38M ﹤0.01%
4,888
-2,129
-30% -$955K
TBPH icon
1283
Theravance Biopharma
TBPH
$875M
$2.37M ﹤0.01%
214,712
ZEN
1284
DELISTED
ZENDESK INC
ZEN
$2.37M ﹤0.01%
22,724
-56,099
-71% -$6.01M
LTHM
1285
DELISTED
Livent Corporation
LTHM
$2.37M ﹤0.01%
97,088
+1,274
+1% +$34.6K
HAE icon
1286
Haemonetics
HAE
$3.75B
$2.36M ﹤0.01%
44,555
+1,039
+2% +$63.3K
BC icon
1287
Brunswick
BC
$5.33B
$2.36M ﹤0.01%
23,444
WNC icon
1288
Wabash National
WNC
$541M
$2.36M ﹤0.01%
120,899
+2,929
+2% +$50.9K
EQC
1289
DELISTED
Equity Commonwealth
EQC
$2.35M ﹤0.01%
93,197
-60,118
-39% -$1.57M
ARWR icon
1290
Arrowhead Research
ARWR
$12.1B
$2.35M ﹤0.01%
35,450
+505
+1% +$34.7K
DOX icon
1291
Amdocs
DOX
$5.83B
$2.35M ﹤0.01%
31,400
CNC icon
1292
Centene
CNC
$31.6B
$2.34M ﹤0.01%
28,411
-17,927
-39% -$1.31M
FCOM icon
1293
Fidelity MSCI Communication Services Index ETF
FCOM
$1.8B
$2.33M ﹤0.01%
45,288
LUMN icon
1294
Lumen
LUMN
$6.38B
$2.32M ﹤0.01%
185,028
-42,492
-19% -$541K
LEN icon
1295
Lennar Class A
LEN
$21.1B
$2.31M ﹤0.01%
20,513
-7,038
-26% -$719K
FFIV icon
1296
F5
FFIV
$22.8B
$2.3M ﹤0.01%
9,409
-780
-8% -$173K
DY icon
1297
Dycom Industries
DY
$12.1B
$2.29M ﹤0.01%
24,464
+224
+0.9% +$18.9K
AAWW
1298
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$2.29M ﹤0.01%
24,301
KSI
1299
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$2.27M ﹤0.01%
234,150
CXT icon
1300
Crane NXT
CXT
$3.14B
$2.24M ﹤0.01%
63,479

Similar funds

Macquarie Group's Q4 2021 Portfolio in Review

As of Q4 2021, Macquarie Group held 2,691 positions worth $120B, up 2.3% from $117B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group withdrew a net $4.47B in Q4 2021, closing 96 positions and reducing 1,008 holdings. Its most notable exit was SK Telecom, an estimated $256M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in GlobalFoundries worth $182M.

  • Macquarie Group's largest Q4 2021 buy was GlobalFoundries: 2,804,906 shares worth $182M.
  • Macquarie Group added most to TJX Companies in Q4 2021, an estimated $505M increase.
  • Macquarie Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $733M.
  • Macquarie Group fully exited SK Telecom in Q4 2021, selling an estimated $256M.
  • Macquarie Group's ten largest holdings make up 13% of its $120B portfolio in Q4 2021.
  • Macquarie Group opened 107 new positions and closed 96 in Q4 2021.
  • Macquarie Group's portfolio value rose 2.3% quarter-over-quarter to $120B.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.